Recombinant Human Ephrin-A4/EFNA4 Protein (Fc & His Tag)(Active)
SKU: PKSH032392-50
Recombinant Human Ephrin-A4/EFNA4 Protein (Fc & His Tag)(Active)
SKU # | PKSH032392 |
Expression Host | HEK293 Cells |
Description
Synonyms | EFNA4, EPH-Related Receptor Tyrosine Kinase Ligand 4, EPLG4, Ephrin-A4, LERK-4, LERK4 |
Species | Human |
Expression Host | HEK293 Cells |
Sequence | Leu26-Gly171 |
Accession | P52798 |
Calculated Molecular Weight | 44.3 kDa |
Observed Molecular Weight | 45 kDa |
Tag | C-Fc-His |
Bio-activity | Immobilized Human EphA7-His(Cat: PKSH033689) at 2μg/ml(100 μl/well) can bind Human EFNA4-Fc-6His. The ED50 of Human EFNA4-Fc-6His is 1. 5190 ug/ml. |
Properties
Purity | > 95 % as determined by reducing SDS-PAGE. |
Endotoxin | < 1.0 EU per μg of the protein as determined by the LAL method. |
Storage | Generally, lyophilized proteins are stable for up to 12 months when stored at -20 to -80℃. Reconstituted protein solution can be stored at 4-8℃ for 2-7 days. Aliquots of reconstituted samples are stable at < -20℃ for 3 months. |
Shipping | This product is provided as lyophilized powder which is shipped with ice packs. |
Formulation | Lyophilized from a 0.2 μm filtered solution of PBS, pH 7.4. Normally 5% - 8% trehalose, mannitol and 0.01% Tween 80 are added as protectants before lyophilization. Please refer to the specific buffer information in the printed manual. |
Reconstitution | Please refer to the printed manual for detailed information. |
Background
Ephrin-A4 is a member of the ephrin ligand family which binds members of the Eph receptor family. All ligands share a conserved extracellular sequence; which most likely corresponds to the receptor binding domain. Ephrin-A4 consists of approximately 125 amino acids and includes four invariant cysteines; It has been shown to bind EphA2; EphA3; EphA4; EphA5; EphA6; EphA7; and EphB1. Ephrin-A4 binds promiscuously Eph receptors residing on adjacent cells; leading to contact-dependent bidirectional signaling into neighboring cells. It may play a role in the interaction between activated B-lymphocytes and dendritic cells in tonsils.